Copyright Reports & Markets. All rights reserved.

COVID-19 Impact on Global Bacterial and Viral Antigens Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Bacterial and Viral Antigens Revenue
  • 1.4 Covid-19 Implications on Market by Pathogen Type
    • 1.4.1 Global Bacterial and Viral Antigens Market Size Growth Rate by Pathogen Type: 2020 VS 2026
    • 1.4.2 Inactivated Pathogen
    • 1.4.3 Purified Pathogen
  • 1.5 Market by Application
    • 1.5.1 Global Bacterial and Viral Antigens Market Share by Application: 2020 VS 2026
    • 1.5.2 Hospitals and Clinics
    • 1.5.3 Diagnostic Laboratories
    • 1.5.4 Academic and Research Institutes
  • 1.6 Coronavirus Disease 2019 (Covid-19): Bacterial and Viral Antigens Industry Impact
    • 1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
    • 1.6.2 Covid-19 Impact: Commodity Prices Indices
    • 1.6.3 Covid-19 Impact: Global Major Government Policy
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Global Growth Trends

  • 2.1 Covid-19 Implications on Global Bacterial and Viral Antigens Market Perspective (2015-2026)
  • 2.2 Covid-19 Implications on Global Bacterial and Viral Antigens Growth Trends by Regions
    • 2.2.1 Bacterial and Viral Antigens Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Bacterial and Viral Antigens Historic Market Share by Regions (2015-2020)
    • 2.2.3 Bacterial and Viral Antigens Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Bacterial and Viral Antigens Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Bacterial and Viral Antigens Players (Opinion Leaders)

3 Covid-19 Implications on Competition Landscape by Key Players

  • 3.1 Global Top Bacterial and Viral Antigens Players by Market Size
    • 3.1.1 Global Top Bacterial and Viral Antigens Players by Revenue (2015-2020)
    • 3.1.2 Global Bacterial and Viral Antigens Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Bacterial and Viral Antigens Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Bacterial and Viral Antigens Market Concentration Ratio
    • 3.2.1 Global Bacterial and Viral Antigens Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Bacterial and Viral Antigens Revenue in 2019
  • 3.3 Bacterial and Viral Antigens Key Players Head office and Area Served
  • 3.4 Key Players Bacterial and Viral Antigens Product Solution and Service
  • 3.5 Date of Enter into Bacterial and Viral Antigens Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Covid-19 Implications on Market Size by Pathogen Type (2015-2026)

  • 4.1 Global Bacterial and Viral Antigens Historic Market Size by Pathogen Type (2015-2020)
  • 4.2 Global Bacterial and Viral Antigens Forecasted Market Size by Pathogen Type (2021-2026)

5 Covid-19 Implications on Market Size by Application (2015-2026)

  • 5.1 Global Bacterial and Viral Antigens Market Size by Application (2015-2020)
  • 5.2 Global Bacterial and Viral Antigens Forecasted Market Size by Application (2021-2026)

6 North America Impact of COVID-19

  • 6.1 North America Bacterial and Viral Antigens Market Size (2015-2020)
  • 6.2 Bacterial and Viral Antigens Key Players in North America (2019-2020)
  • 6.3 North America Bacterial and Viral Antigens Market Size by Pathogen Type (2015-2020)
  • 6.4 North America Bacterial and Viral Antigens Market Size by Application (2015-2020)

7 Europe Impact of COVID-19

  • 7.1 Europe Bacterial and Viral Antigens Market Size (2015-2020)
  • 7.2 Bacterial and Viral Antigens Key Players in Europe (2019-2020)
  • 7.3 Europe Bacterial and Viral Antigens Market Size by Pathogen Type (2015-2020)
  • 7.4 Europe Bacterial and Viral Antigens Market Size by Application (2015-2020)

8 China Impact of COVID-19

  • 8.1 China Bacterial and Viral Antigens Market Size (2015-2020)
  • 8.2 Bacterial and Viral Antigens Key Players in China (2019-2020)
  • 8.3 China Bacterial and Viral Antigens Market Size by Pathogen Type (2015-2020)
  • 8.4 China Bacterial and Viral Antigens Market Size by Application (2015-2020)

9 Japan Impact of COVID-19

  • 9.1 Japan Bacterial and Viral Antigens Market Size (2015-2020)
  • 9.2 Bacterial and Viral Antigens Key Players in Japan (2019-2020)
  • 9.3 Japan Bacterial and Viral Antigens Market Size by Pathogen Type (2015-2020)
  • 9.4 Japan Bacterial and Viral Antigens Market Size by Application (2015-2020)

10 Southeast Asia Impact of COVID-19

  • 10.1 Southeast Asia Bacterial and Viral Antigens Market Size (2015-2020)
  • 10.2 Bacterial and Viral Antigens Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Bacterial and Viral Antigens Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Bacterial and Viral Antigens Market Size by Application (2015-2020)

11 India Impact of COVID-19

  • 11.1 India Bacterial and Viral Antigens Market Size (2015-2020)
  • 11.2 Bacterial and Viral Antigens Key Players in India (2019-2020)
  • 11.3 India Bacterial and Viral Antigens Market Size by Type (2015-2020)
  • 11.4 India Bacterial and Viral Antigens Market Size by Application (2015-2020)

12 Central & South America Impact of COVID-19

  • 12.1 Central & South America Bacterial and Viral Antigens Market Size (2015-2020)
  • 12.2 Bacterial and Viral Antigens Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Bacterial and Viral Antigens Market Size by Type (2015-2020)
  • 12.4 Central & South America Bacterial and Viral Antigens Market Size by Application (2015-2020)

13Key Players Profiles

  • 13.1 The Native Antigen Company
    • 13.1.1 The Native Antigen Company Company Details
    • 13.1.2 The Native Antigen Company Business Overview and Its Total Revenue
    • 13.1.3 The Native Antigen Company Bacterial and Viral Antigens Introduction
    • 13.1.4 The Native Antigen Company Revenue in Bacterial and Viral Antigens Business (2015-2020))
    • 13.1.5 The Native Antigen Company Recent Development and Reaction to COVID-19
  • 13.2 Creative Diagnostics
    • 13.2.1 Creative Diagnostics Company Details
    • 13.2.2 Creative Diagnostics Business Overview and Its Total Revenue
    • 13.2.3 Creative Diagnostics Bacterial and Viral Antigens Introduction
    • 13.2.4 Creative Diagnostics Revenue in Bacterial and Viral Antigens Business (2015-2020)
    • 13.2.5 Creative Diagnostics Recent Development and Reaction to COVID-19
  • 13.3 Microbix Biosystems
    • 13.3.1 Microbix Biosystems Company Details
    • 13.3.2 Microbix Biosystems Business Overview and Its Total Revenue
    • 13.3.3 Microbix Biosystems Bacterial and Viral Antigens Introduction
    • 13.3.4 Microbix Biosystems Revenue in Bacterial and Viral Antigens Business (2015-2020)
    • 13.3.5 Microbix Biosystems Recent Development and Reaction to COVID-19
  • 13.4 SERION Immunologics
    • 13.4.1 SERION Immunologics Company Details
    • 13.4.2 SERION Immunologics Business Overview and Its Total Revenue
    • 13.4.3 SERION Immunologics Bacterial and Viral Antigens Introduction
    • 13.4.4 SERION Immunologics Revenue in Bacterial and Viral Antigens Business (2015-2020)
    • 13.4.5 SERION Immunologics Recent Development and Reaction to COVID-19
  • 13.5 Bio-Rad Laboratories
    • 13.5.1 Bio-Rad Laboratories Company Details
    • 13.5.2 Bio-Rad Laboratories Business Overview and Its Total Revenue
    • 13.5.3 Bio-Rad Laboratories Bacterial and Viral Antigens Introduction
    • 13.5.4 Bio-Rad Laboratories Revenue in Bacterial and Viral Antigens Business (2015-2020)
    • 13.5.5 Bio-Rad Laboratories Recent Development and Reaction to COVID-19
  • 13.6 Enzo Life Sciences
    • 13.6.1 Enzo Life Sciences Company Details
    • 13.6.2 Enzo Life Sciences Business Overview and Its Total Revenue
    • 13.6.3 Enzo Life Sciences Bacterial and Viral Antigens Introduction
    • 13.6.4 Enzo Life Sciences Revenue in Bacterial and Viral Antigens Business (2015-2020)
    • 13.6.5 Enzo Life Sciences Recent Development and Reaction to COVID-19
  • 13.7 Jena Bioscience GmbH
    • 13.7.1 Jena Bioscience GmbH Company Details
    • 13.7.2 Jena Bioscience GmbH Business Overview and Its Total Revenue
    • 13.7.3 Jena Bioscience GmbH Bacterial and Viral Antigens Introduction
    • 13.7.4 Jena Bioscience GmbH Revenue in Bacterial and Viral Antigens Business (2015-2020)
    • 13.7.5 Jena Bioscience GmbH Recent Development and Reaction to COVID-19
  • 13.8 QED Bioscience
    • 13.8.1 QED Bioscience Company Details
    • 13.8.2 QED Bioscience Business Overview and Its Total Revenue
    • 13.8.3 QED Bioscience Bacterial and Viral Antigens Introduction
    • 13.8.4 QED Bioscience Revenue in Bacterial and Viral Antigens Business (2015-2020)
    • 13.8.5 QED Bioscience Recent Development and Reaction to COVID-19
  • 13.9 Ross Southern Laboratories
    • 13.9.1 Ross Southern Laboratories Company Details
    • 13.9.2 Ross Southern Laboratories Business Overview and Its Total Revenue
    • 13.9.3 Ross Southern Laboratories Bacterial and Viral Antigens Introduction
    • 13.9.4 Ross Southern Laboratories Revenue in Bacterial and Viral Antigens Business (2015-2020)
    • 13.9.5 Ross Southern Laboratories Recent Development and Reaction to COVID-19
  • 13.10 AROTEC Diagnostics
    • 13.10.1 AROTEC Diagnostics Company Details
    • 13.10.2 AROTEC Diagnostics Business Overview and Its Total Revenue
    • 13.10.3 AROTEC Diagnostics Bacterial and Viral Antigens Introduction
    • 13.10.4 AROTEC Diagnostics Revenue in Bacterial and Viral Antigens Business (2015-2020)
    • 13.10.5 AROTEC Diagnostics Recent Development and Reaction to COVID-19

14Analyst's Viewpoints/Conclusions

    15Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    Bacterial and Viral Antigens market is segmented by Pathogen Type, and by Application. Players, stakeholders, and other participants in the global Bacterial and Viral Antigens market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Pathogen Type and by Application in terms of revenue and forecast for the period 2015-2026.
    Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 200 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Bacterial and Viral Antigens market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
    This report also analyzes the impact of Coronavirus COVID-19 on the Bacterial and Viral Antigens industry.

    The key players covered in this study
    The Native Antigen Company
    Creative Diagnostics
    Microbix Biosystems
    SERION Immunologics
    Bio-Rad Laboratories
    Enzo Life Sciences
    Jena Bioscience GmbH
    QED Bioscience
    Ross Southern Laboratories
    AROTEC Diagnostics

    Market segment by Pathogen Type, the product can be split into
    Inactivated Pathogen
    Purified Pathogen
    Market segment by Application, split into
    Hospitals and Clinics
    Diagnostic Laboratories
    Academic and Research Institutes

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    The study objectives of this report are:
    To analyze global Bacterial and Viral Antigens status, future forecast, growth opportunity, key market and key players.
    To present the Bacterial and Viral Antigens development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
    To strategically profile the key players and comprehensively analyze their development plan and strategies.
    To define, describe and forecast the market by pathogen type, market and key regions.

    In this study, the years considered to estimate the market size of Bacterial and Viral Antigens are as follows:
    History Year: 2015-2019
    Base Year: 2019
    Estimated Year: 2020
    Forecast Year 2020 to 2026
    For the data information by region, company, pathogen type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
    Buy now